查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1984127

神經外科手術室人工智慧市場：按組件、技術、部署方式、手術類型、目標部位、應用和最終用戶分類——2026年至2032年全球市場預測

Artificial Intelligence in Neurology Operating Room Market by Component, Technology, Deployment, Surgery Type, Anatomy Target, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年，神經外科手術室人工智慧 (AI) 市場價值為 40.6 億美元，預計到 2026 年將成長至 46.8 億美元，複合年成長率為 16.08%，到 2032 年將達到 115.4 億美元。

主要市場統計數據
基準年 2025 40.6億美元
預計年份：2026年 46.8億美元
預測年份 2032 115.4億美元
複合年成長率 (%) 16.08%

權威說明，闡述人工智慧如何即時改變神經外科手術工作流程、術中決策和手術室效率。

手術室正朝著智慧化方向發展，人工智慧即時輔助手術決策、影像診斷和器械控制。在神經病學領域，這些進步與需要極高精度、動態術中成像以及生理和影像數據持續分析的手術密切相關。本執行摘要在於臨床需求與人工智慧解決方案的交會點，說明這些技術如何整合重塑圍手術全期工作流程和臨床醫師的工作環境。

診斷影像、導航、機器人技術和服務模式的進步融合，為神經外科手術室和採購系統帶來了系統性的改變。

神經外科手術室的環境正在經歷一場變革，這主要得益於感測技術、機器感知和機器人精準度的不斷成熟。目前，成像系統能夠提供高精度的資料流，人工智慧模型可在術中對這些資料進行分析，從而實現即時組織表徵、切緣檢測和導航校正。同時，導航平台與機器人系統和分析層的整合度也不斷提高，推動手術領域朝向協作式、半自動的任務執行模式發展，進而減輕手術團隊的認知負荷。

分析關稅調整和貿易政策趨勢如何重塑用於神經外科應用的人工智慧系統的供應鏈、籌資策略和採購實踐。

政策變化和關稅調整會對高度複雜的醫療技術領域的供應鏈、零件採購和籌資策略產生連鎖反應。在近期關稅措施和貿易不確定性下，製造商和醫療系統正面臨零件成本上漲、前置作業時間延長且更難以預測，以及重新評估供應商集中度風險的必要性。包含精密機械部件、先進成像檢測器或專用伺服馬達的硬體組件尤其容易受到進口關稅和貿易壁壘變化的影響。

從綜合細分的觀點，將組件、應用程式、使用者、技術、部署模型和手術方法連結起來，揭示採用的促進因素和價值來源。

以細分觀點，可以清楚闡明價值創造的來源，以及不同產品層級、臨床應用和客戶類型之間的投資重點差異。從組件層面來看，硬體仍然是基礎，影像、導航和機器人系統構成了與患者和臨床團隊的直接接觸點，而服務和軟體則驅動著永續營運和臨床價值提案。整合、維護和培訓服務對於釋放硬體的效用至關重要，而人工智慧平台、分析軟體和預測演算法則是提升術中決策品質和工作流程效率的關鍵促進因素。

美洲、歐洲、中東和非洲以及亞太地區的不同管理體制、採購模式和臨床基礎設施如何影響部署軌跡和供應商策略？

區域趨勢對技術採納、監管參與和臨床檢驗過程有顯著影響。在美洲，醫療保健系統通常優先考慮基於結果的採購、強大的機構研究網路以及對早期臨床檢驗的投資意願，這加速了試驗計畫和迭代部署。專業神經外科中心和集中式學術中心的存在也支持快速產生證據和開展臨床醫生培訓舉措，從而促進技術的更廣泛應用。

競爭對手與策略挑戰：致力於透過整合解決方案、臨床證據產生和創新經營模式。

主要企業的行動都圍繞著幾個策略重點展開，這些重點決定了它們的市場定位和長期競爭力。首先，能夠整合端到端解決方案（將影像和導航硬體與檢驗的人工智慧軟體以及強大的服務交付相結合）的企業，可以提高客戶的轉換成本，並為高額合約模式提供合理的依據。其次，臨床系統整合商、影像設備供應商和專業人工智慧開發商之間的夥伴關係正逐漸成為加速監管申報和臨床試驗、以及共用風險和證據產生責任的標準模式。

為市場領導提供可操作的策略措施，以加速採用、降低採用風險，並使經營模式與臨床結果和採購實際情況保持一致。

產業領導者必須採取一系列平衡的策略步驟，協調臨床檢驗、採購流程複雜性和技術差異化。優先透過多中心研究和臨床醫生主導的初步試驗來建立可驗證的臨床證據，這些試驗不僅要衡量技術精確性，還要衡量對工作流程的影響、使用者接受度和後續臨床結果。同時，制定商業提案，應將整合、培訓和維護服務與硬體和軟體捆綁銷售，從而降低客戶風險，減少早期採用者的營運摩擦。

結合臨床醫師訪談、技術評估、監管審查和供應鏈分析等多方面研究途徑，得出基於證據的結論。

本報告的調查方法結合了初步研究和嚴謹的二次研究，並輔以臨床檢驗，以確保研究結果具有實證性和可操作性。初步研究包括對第一線神經外科醫生、手術室護士、生物醫學工程師、醫院採購負責人和技術部門主管進行結構化訪談，並在條件允許的情況下輔以對術中工作流程的直接觀察。這些初步研究結果與設備技術規格、監管申報文件和同行評審的臨床文獻進行交叉比對，以檢驗結論並為結果提供背景資訊。

本文概述了臨床檢驗、互通性設計和穩健的商業策略如何為人工智慧在神經外科領域的持續應用奠定基礎。

人工智慧正從一項前景看好的輔助技術，發展成為支撐更安全、更精準的神經外科手術的基礎層。這項技術的價值在於硬體精度、檢驗的演算法和服務模式的融合，從而降低術中不確定性，提高手術效率，並擴展專家知識。然而，實現這一願景需要嚴格的臨床檢驗、可互操作系統設計、穩健的供應鏈以及能夠協調供應商和醫療服務提供者獎勵的完善商業模式。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：神經外科手術室人工智慧市場：按組件分類

  • 硬體
    • 醫學影像系統
    • 導航系統
    • 機器人系統
  • 服務
    • 綜合服務
    • 維護服務
    • 培訓服務
  • 軟體
    • 人工智慧平台
    • 分析軟體
    • 預測演算法

第9章：神經外科手術室人工智慧市場：依技術分類

  • 電腦視覺
    • 3D重建
    • 影像分割
  • 深度學習
    • 卷積類神經網路
    • 循環神經網路
  • 機器學習
    • 監督式學習
    • 無監督學習
  • 自然語言處理
    • 臨床報告分析
    • 文獻挖掘

第10章：神經外科手術室人工智慧市場：以部署方式分類

  • 雲
  • 現場

第11章：神經外科手術室人工智慧市場（依手術類型分類）

  • 深部腦部刺激療法
  • 癲癇手術
  • 腫瘤切除

第12章：神經外科手術室人工智慧市場（依解剖科目分類）

  • 腦
  • 脊髓

第13章：神經外科手術室人工智慧市場：按應用領域分類

  • 術中影像診斷
    • CT
    • MRI
    • 超音波
  • 預測分析
    • 結果預測
    • 工作流程最佳化
  • 機器人支援
    • 神經科學用內視鏡機器人
    • 機器人輔助顯微手術
  • 手術導引
    • 電磁導航
    • 光學導航

第14章：神經外科手術室人工智慧市場：依最終用戶分類

  • 門診手術中心
  • 醫院和診所
  • 研究機構

第15章：神經外科手術室人工智慧市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章：神經外科手術室人工智慧市場：按類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章：神經外科手術室人工智慧市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國神經外科手術室的人工智慧市場

第19章：中國神經外科手術室的人工智慧市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Activ Surgical Inc.
  • Brainomix Limited
  • Caresyntax Corporation
  • DeepOR SAS
  • ExplORer Surgical Corp.
  • GE HealthCare Technologies, Inc.
  • Getinge AB
  • Hill-Rom Holdings, Inc.
  • Holo Surgical Inc.
  • IMRIS inc.
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & CO. KG
  • Koninklijke Philips NV
  • LeanTaaS Inc.
  • Medtronic PLC
  • NeuroOne Medical Technologies Corporation
  • Proximie Limited
  • Scalpel Limited
  • Siemens Healthcare GmbH
  • Stryker Corporation
  • Surgalign Spine Technologies Inc.
  • Surgical Theater, Inc.
  • Theator Inc.
  • Toshiba Corporation
Product Code: MRR-5C6F41F5AF3E

The Artificial Intelligence in Neurology Operating Room Market was valued at USD 4.06 billion in 2025 and is projected to grow to USD 4.68 billion in 2026, with a CAGR of 16.08%, reaching USD 11.54 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.06 billion
Estimated Year [2026] USD 4.68 billion
Forecast Year [2032] USD 11.54 billion
CAGR (%) 16.08%

An authoritative orientation to how artificial intelligence is reshaping neurosurgical workflows, intraoperative decision-making, and operating room efficiency in real time

The operating room is evolving into an intelligent environment where artificial intelligence augments surgical decision-making, imaging interpretation, and device control in real time. In neurology, these advances intersect with procedures that demand extreme precision, dynamic intraoperative imaging, and continuous interpretation of physiological and imaging data. This executive summary frames the intersection of clinical imperatives and AI-enabled solutions, focusing on how technologies are converging to redefine perioperative workflows and clinician ergonomics.

Across procedural stages, AI is moving from adjunctive analytics toward embedded functionality that supports image-guided resection, robotic assistance, and predictive workflow orchestration. The content that follows distills core shifts in technology, clinical validation priorities, supplier models, and regulatory considerations that stakeholders must weigh. It is intended to orient senior executives, clinical leaders, and commercialization teams to the strategic choices that will determine adoption velocity and clinical impact over the coming years.

How converging advances in imaging, navigation, robotics, and service models are driving systemic transformation in neurosurgical operating rooms and procurement

The landscape of neurology operating theaters is experiencing transformative shifts driven by the maturation of sensing modalities, machine perception, and robotic precision. Imaging systems now feed high-fidelity data streams that AI models can analyze intraoperatively, enabling real-time tissue characterization, margin detection, and navigation corrections. Concurrently, navigation platforms are becoming more tightly integrated with robotic systems and analytics layers, moving the field toward coordinated, semi-autonomous task execution that reduces cognitive load on surgical teams.

These shifts are reinforced by expanding lines of service that accompany hardware and software deployments. Integration services are evolving to cover data orchestration and interoperability across legacy imaging modalities, while training and maintenance services are critical to sustain clinical confidence and uptime. As a result, business models are transitioning from pure capital equipment sales to bundled solutions that combine devices, predictive software, and ongoing clinical support. This systemic evolution is altering procurement criteria, clinician training curricula, and capital planning priorities across health systems.

Analysis of how tariff adjustments and trade policy dynamics are reshaping supply chains, sourcing strategies, and procurement behavior for neurosurgical AI systems

Policy changes and tariff adjustments can have cascading effects across supply chains, component sourcing, and procurement strategies for high-complexity medical technologies. In the context of recent tariff actions and trade uncertainties, manufacturers and health systems face upward pressure on component costs, longer and less predictable lead times, and the need to reassess supplier concentration risks. Hardware elements that incorporate precision mechanical components, advanced imaging detectors, or specialized servomotors are particularly exposed to shifts in import duties and trade barriers.

Over time, these pressures tend to accelerate supplier diversification and localization strategies, prompting device makers to onshore or nearshore key assembly and subassembly operations where feasible. Software and cloud-based services experience a different set of impacts: while they are less vulnerable to physical tariffs, they are affected by cross-border data transfer policies, hosting costs, and contractual obligations that can increase total cost of ownership. Health systems responding to procurement cost pressures may prioritize modular architectures, standardized interfaces, and service agreements that transfer certain risks to vendors. Clinically, tariff-driven disruptions can slow replacement cycles and delay the diffusion of newer, more capable systems, creating a temporal gap between capability availability and broad clinical adoption. As stakeholders recalibrate, the emphasis on robust supplier governance, multi-year procurement contracts, and strategic inventory management will grow.

An integrated segmentation perspective that links components, applications, users, technologies, deployments, and surgical procedures to reveal adoption drivers and value pools

A segmentation-aware view clarifies where value accrues and how investment priorities differ across product layers, clinical uses, and customer types. Component-level distinctions reveal that hardware remains foundational, with imaging systems, navigation systems, and robotic systems forming the tangible interface to the patient and clinical team, while services and software create the sustained operational and clinical value proposition. Integration, maintenance, and training services are increasingly pivotal for unlocking hardware utility, and AI platforms, analytics software, and predictive algorithms are the primary levers for improving intraoperative decision quality and workflow efficiency.

Application segmentation shapes requirements for latency, validation, and regulatory evidence. Intraoperative imaging modalities-CT, MRI, and ultrasound-have differing constraints and integration needs, while predictive analytics use cases such as outcome prediction and workflow optimization demand longitudinal clinical data and interoperability. Robotic assistance spans neuroendoscopic robots and robot-assisted microscopy, each with distinct control, haptics, and reliability expectations. End-user typologies, including ambulatory surgical centers, hospitals and clinics, and research institutes, create diverse procurement and deployment preferences that influence service models and support levels. Technology choices-computer vision with 3D reconstruction and image segmentation, deep learning instantiated through convolutional and recurrent architectures, machine learning with supervised and unsupervised approaches, and natural language processing applied to clinical report analysis and literature mining-determine validation pathways and compute requirements. Deployment options between cloud and on-premise environments influence data governance, latency, and upgrade cadence. Clinical procedure focus areas such as deep brain stimulation, epilepsy surgery, and tumor resection, and anatomical targets including brain and spinal cord, further refine requirements for precision, registration, and intraoperative feedback loops. Viewing the market through these intersecting segmentation lenses helps reveal where clinical need, technical feasibility, and procurement criteria align to accelerate adoption.

How distinct regulatory regimes, procurement models, and clinical infrastructures across the Americas, EMEA, and Asia-Pacific are shaping adoption trajectories and vendor strategies

Regional dynamics materially influence technology adoption, regulatory interaction, and clinical validation pathways. In the Americas, health systems often emphasize outcome-driven procurement, strong institutional research networks, and a willingness to invest in early clinical validation, which accelerates pilot programs and iterative deployments. The availability of specialized neurosurgical centers and concentrated academic hubs also supports rapid evidence generation and clinician training initiatives that catalyze broader uptake.

Across Europe, the Middle East and Africa, the regulatory landscape and reimbursement frameworks shape deployment timing and required evidence packages. Cost containment pressures in some jurisdictions increase demand for scalable, interoperable solutions that demonstrate clear improvements in throughput or clinical outcomes. Meanwhile, capacity constraints and uneven access to subspecialty care in parts of the region create opportunities for remote support models and cloud-enabled analytics to extend expertise. In the Asia-Pacific region, a combination of rapid hospital expansion, government-led technology adoption programs, and a competitive local manufacturing base drives heterogeneity in procurement strategies. The region often balances aggressive adoption of robotics and imaging with a strong emphasis on cost-effectiveness and supply chain resilience.

Competitive behaviors and strategic imperatives for companies pursuing leadership through integrated solutions, clinical evidence generation, and innovative commercial models

Key company behaviors cluster around several strategic priorities that determine market positioning and long-term competitiveness. First, firms that integrate end-to-end solutions-combining imaging or navigation hardware with validated AI software and robust service offerings-create higher switching costs for customers and can justify premium contracting models. Second, partnerships between clinical systems integrators, imaging vendors, and specialist AI developers are becoming the norm to accelerate regulatory submissions and clinical studies, sharing both risk and evidence-generation responsibilities.

Third, successful companies invest in longitudinal clinical validation and real-world evidence programs that demonstrate safety, reproducibility, and workflow impact; these programs are instrumental in gaining clinician trust and payer recognition. Fourth, firms that design for modularity and interoperability reduce integration friction with existing hospital infrastructures, which shortens procurement cycles. Finally, commercial models diversify beyond capital sales to include managed services, outcome-based contracts, and subscription licensing for analytics, aligning vendor incentives with clinical performance and operational uptime. Observing these behaviors helps inform competitive responses and potential partnership targets.

Actionable strategic moves for market leaders to accelerate adoption, de-risk deployments, and align commercial models with clinical outcomes and procurement realities

Industry leaders must pursue a balanced set of strategic moves that align clinical validation, procurement complexity, and technological differentiation. Prioritize building demonstrable clinical evidence through multi-center studies and clinician-led pilots that measure not only technical accuracy but also workflow impact, user acceptance, and downstream clinical outcomes. Simultaneously, structure commercial offers to reduce customer risk by bundling integration, training, and maintenance services with hardware and software, thereby lowering operational friction for early adopters.

To mitigate supply-chain and policy risks, diversify component sourcing and consider selective localization for critical assemblies. Invest in interoperable architectures and open APIs to ease integration with hospital information systems and existing imaging fleets. From a technology standpoint, focus development on explainable models and human-in-the-loop interfaces that enhance surgeon control and regulatory acceptability. Finally, cultivate partnerships with leading clinical centers and payers to build shared value propositions that link technology deployment to demonstrable improvements in clinical and operational metrics.

A robust multi-method research approach combining clinician interviews, technology assessment, regulatory review, and supply chain mapping to ensure evidence-based conclusions

The report's methodology combines primary research with rigorous secondary analysis and clinical validation to ensure findings are evidence-based and actionable. Primary inputs include structured interviews with practicing neurosurgeons, operating room nurses, biomedical engineers, hospital procurement officers, and technology executives, supplemented by direct observation of intraoperative workflows where available. These primary insights are triangulated with device technical specifications, regulatory filings, and peer-reviewed clinical literature to verify claims and contextualize results.

Technology assessments evaluate algorithmic approaches, training datasets, compute footprints, and integration complexity. Supply chain mapping traces component origins, assembly locations, and logistics risks to surface vulnerabilities. Regulatory reviews encompass device classification, approval timelines, and post-market surveillance obligations. Data synthesis employed a layered approach that weights clinical impact, technical readiness, and commercial viability to produce balanced recommendations while avoiding quantitative market sizing beyond the scope of qualitative and evidentiary analysis.

Concluding synthesis on how clinical validation, interoperable design, and resilient commercial strategies form the foundation for lasting adoption of AI in neurosurgery

Artificial intelligence is transitioning from a promising adjunct to a foundational layer that supports safer, more precise neurosurgical procedures. The technology's value is realized when hardware fidelity, validated algorithms, and service models coalesce to reduce intraoperative uncertainty, improve procedural efficiency, and extend specialist expertise. However, achieving this future depends on disciplined clinical validation, interoperable system design, resilient supply chains, and thoughtful commercial models that align incentives between vendors and clinical institutions.

Stakeholders who invest in modular architectures, longitudinal evidence programs, and strong clinician engagement programs will be best positioned to capture the clinical and economic benefits of AI-enabled neurosurgery. Policymakers and hospital leaders should encourage frameworks that reward demonstrable improvements in patient outcomes and operational performance, while vendors should emphasize explainability, reliability, and supportability as core product attributes. Taken together, these elements form the foundation for sustained, responsible adoption of AI in neurology operating rooms.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Intelligence in Neurology Operating Room Market, by Component

  • 8.1. Hardware
    • 8.1.1. Imaging Systems
    • 8.1.2. Navigation Systems
    • 8.1.3. Robotic Systems
  • 8.2. Services
    • 8.2.1. Integration Services
    • 8.2.2. Maintenance Services
    • 8.2.3. Training Services
  • 8.3. Software
    • 8.3.1. AI Platforms
    • 8.3.2. Analytics Software
    • 8.3.3. Predictive Algorithms

9. Artificial Intelligence in Neurology Operating Room Market, by Technology

  • 9.1. Computer Vision
    • 9.1.1. 3D Reconstruction
    • 9.1.2. Image Segmentation
  • 9.2. Deep Learning
    • 9.2.1. Convolutional Neural Networks
    • 9.2.2. Recurrent Neural Networks
  • 9.3. Machine Learning
    • 9.3.1. Supervised Learning
    • 9.3.2. Unsupervised Learning
  • 9.4. Natural Language Processing
    • 9.4.1. Clinical Report Analysis
    • 9.4.2. Literature Mining

10. Artificial Intelligence in Neurology Operating Room Market, by Deployment

  • 10.1. Cloud
  • 10.2. On Premise

11. Artificial Intelligence in Neurology Operating Room Market, by Surgery Type

  • 11.1. Deep Brain Stimulation
  • 11.2. Epilepsy Surgery
  • 11.3. Tumor Resection

12. Artificial Intelligence in Neurology Operating Room Market, by Anatomy Target

  • 12.1. Brain
  • 12.2. Spinal Cord

13. Artificial Intelligence in Neurology Operating Room Market, by Application

  • 13.1. Intraoperative Imaging
    • 13.1.1. CT
    • 13.1.2. MRI
    • 13.1.3. Ultrasound
  • 13.2. Predictive Analytics
    • 13.2.1. Outcome Prediction
    • 13.2.2. Workflow Optimization
  • 13.3. Robotic Assistance
    • 13.3.1. Neuroendoscopic Robots
    • 13.3.2. Robot-Assisted Microscopy
  • 13.4. Surgical Navigation
    • 13.4.1. Electromagnetic Navigation
    • 13.4.2. Optical Navigation

14. Artificial Intelligence in Neurology Operating Room Market, by End User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Hospitals And Clinics
  • 14.3. Research Institutes

15. Artificial Intelligence in Neurology Operating Room Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Artificial Intelligence in Neurology Operating Room Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Artificial Intelligence in Neurology Operating Room Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Artificial Intelligence in Neurology Operating Room Market

19. China Artificial Intelligence in Neurology Operating Room Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Activ Surgical Inc.
  • 20.6. Brainomix Limited
  • 20.7. Caresyntax Corporation
  • 20.8. DeepOR S.A.S.
  • 20.9. ExplORer Surgical Corp.
  • 20.10. GE HealthCare Technologies, Inc.
  • 20.11. Getinge AB
  • 20.12. Hill-Rom Holdings, Inc.
  • 20.13. Holo Surgical Inc.
  • 20.14. IMRIS inc.
  • 20.15. Johnson & Johnson Services, Inc.
  • 20.16. KARL STORZ SE & CO. KG
  • 20.17. Koninklijke Philips N.V.
  • 20.18. LeanTaaS Inc.
  • 20.19. Medtronic PLC
  • 20.20. NeuroOne Medical Technologies Corporation
  • 20.21. Proximie Limited
  • 20.22. Scalpel Limited
  • 20.23. Siemens Healthcare GmbH
  • 20.24. Stryker Corporation
  • 20.25. Surgalign Spine Technologies Inc.
  • 20.26. Surgical Theater, Inc.
  • 20.27. Theator Inc.
  • 20.28. Toshiba Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEPLOYMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGERY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANATOMY TARGET, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTEGRATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTEGRATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTEGRATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TRAINING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TRAINING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TRAINING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AI PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AI PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AI PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANALYTICS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANALYTICS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ALGORITHMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ALGORITHMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ALGORITHMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY 3D RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY 3D RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY 3D RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGE SEGMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGE SEGMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGE SEGMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SUPERVISED LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SUPERVISED LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY UNSUPERVISED LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY UNSUPERVISED LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CLINICAL REPORT ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CLINICAL REPORT ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CLINICAL REPORT ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY LITERATURE MINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY LITERATURE MINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY LITERATURE MINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP BRAIN STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP BRAIN STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY EPILEPSY SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY EPILEPSY SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY EPILEPSY SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANATOMY TARGET, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY BRAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY BRAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY BRAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SPINAL CORD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SPINAL CORD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SPINAL CORD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OUTCOME PREDICTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OUTCOME PREDICTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OUTCOME PREDICTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NEUROENDOSCOPIC ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NEUROENDOSCOPIC ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NEUROENDOSCOPIC ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOT-ASSISTED MICROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOT-ASSISTED MICROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOT-ASSISTED MICROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OPTICAL NAVIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OPTICAL NAVIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OPTICAL NAVIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANATOMY TARGET, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANATOMY TARGET, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANATOMY TARGET, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGERY TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANATOMY TARGET, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE ARTIFICIAL INTELL